Resource Center
Find the latest content and resources from our team of experts to keep you in the know for all things quality and regulatory in the life science industry.
Sort by topic
Sort by resource type
Eli Lilly is gaining momentum in the obesity treatment landscape following compelling Phase 3 trial results for ...
The U.S. Food and Drug Administration (FDA) has released draft guidance to help sponsors design and assess ...
The rapid growth of cellular and gene therapy development has brought groundbreaking opportunities to patients, ...
Pulse oximeters are critical devices that estimate blood oxygen levels by shining red and infrared light through ...
The Prescription Drug User Fee Act (PDUFA) has reshaped how quickly new therapies reach patients since its ...
“Competitive intelligence in the life sciences is about transforming information into strategic advantage,” said ...
AstraZeneca’s decades-long commitment to precision oncology is showing powerful results, particularly in the ...
A recent joint report from the World Health Organization (WHO) and the United Nations Office on Drugs and Crime ...
The U.S. Food and Drug Administration’s (FDA) Office of Pharmaceutical Quality (OPQ) has released its seventh ...
AI & ML in Clinical Trials explores how artificial intelligence and machine learning are reshaping the design, ...
The U.S. Food and Drug Administration (FDA) has issued a warning letter to Spectra Therapy citing ten violations ...
The European Medicines Agency (EMA) has announced its intention to revise its guideline on the clinical ...
No results found.